Modulation of Sorafenib Induced Autophagy Using Hydroxychloroquine in Hepatocellular Cancer
Phase of Trial: Phase II
Latest Information Update: 05 Feb 2019
At a glance
- Drugs Hydroxychloroquine (Primary) ; Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 25 Jan 2019 Planned End Date changed from 1 Dec 2018 to 1 Dec 2020.
- 25 Jan 2019 Planned primary completion date changed from 1 Dec 2018 to 1 Dec 2019.
- 29 Jan 2018 Status changed from not yet recruiting to recruiting.